BXP
44
6
MDT
44
2
PX
78
2
GM
49
-8
AIZ
71
5
MMC
41
2
LOW
46
6
KIM
50
5
UHS
42
2
FCX
50
3
FOXA
63
7
AA
56
5
VTR
58
3
LEG
29
7
IFF
41
3
VRSK
19
2
HPE
47
2
STX
73
2
LRCX
49
-7
CPB
34
2
BXP
44
6
MDT
44
2
PX
78
2
GM
49
-8
AIZ
71
5
MMC
41
2
LOW
46
6
KIM
50
5
UHS
42
2
FCX
50
3
FOXA
63
7
AA
56
5
VTR
58
3
LEG
29
7
IFF
41
3
VRSK
19
2
HPE
47
2
STX
73
2
LRCX
49
-7
CPB
34
2
Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. Regencell Bioscience Holdings Industry Stock Comparison

Sell
39

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$90.97
Seasonality Move:
-0.71%
Sell
25

RGC
Regencell Bioscience Holdings

Last Price:
$13.29
Seasonality Move:
-8.63%
Sell
39
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Sell

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $90.74. The Score for TDIV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • TDIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy, Sell or Hold?

  • The current Regencell Bioscience Holdings [RGC] share price is $13.76. The Score for RGC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • RGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

  • The First Trust NASDAQ Technology Dividend Index Fund share price today is $90.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGC Stock Price Chart

What is Regencell Bioscience Holdings's stock price today?

  • The Regencell Bioscience Holdings share price today is $13.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.36 Buy
Relative Strength Index (14 RSI): 52.71 Buy
Chaikin Money Flow: 164239 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.69 - 92.23) Sell
Bollinger Bands (100): (73.09 - 89.33) Buy

RGC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.35 Buy
Relative Strength Index (14 RSI): 45.34 Sell
Chaikin Money Flow: 229439 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.78 - 17.58) Sell
Bollinger Bands (100): (-1.38 - 23.98) Buy

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.99 Sell
20-day SMA: 91.54 Sell
50-day SMA: 88.16 Buy
200-day SMA: 80.71 Buy
8-day EMA: 64.83 Buy
20-day EMA: 35.73 Buy
50-day EMA: 16.46 Buy
200-day EMA: 4.43 Buy

RGC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.04 Sell
20-day SMA: 14.81 Sell
50-day SMA: 19.77 Sell
200-day SMA: 5.72 Buy
8-day EMA: 9.71 Buy
20-day EMA: 5.36 Buy
50-day EMA: 2.47 Buy
200-day EMA: 0.67 Buy

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regencell Bioscience Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):